BIANCONI, FORTUNATO
 Distribuzione geografica
Continente #
NA - Nord America 2.925
EU - Europa 2.312
AS - Asia 1.704
SA - Sud America 302
AF - Africa 37
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.286
Nazione #
US - Stati Uniti d'America 2.871
SG - Singapore 771
IE - Irlanda 508
IT - Italia 462
UA - Ucraina 297
CN - Cina 295
HK - Hong Kong 290
BR - Brasile 264
SE - Svezia 244
RU - Federazione Russa 215
DE - Germania 169
VN - Vietnam 153
FI - Finlandia 131
GB - Regno Unito 89
KR - Corea 75
FR - Francia 57
CA - Canada 33
AT - Austria 23
PL - Polonia 22
RO - Romania 22
IN - India 21
TR - Turchia 19
ZA - Sudafrica 15
AR - Argentina 14
IQ - Iraq 14
NL - Olanda 14
BE - Belgio 13
CH - Svizzera 13
JP - Giappone 13
MX - Messico 12
BD - Bangladesh 10
ID - Indonesia 8
CZ - Repubblica Ceca 7
EC - Ecuador 6
GR - Grecia 6
TN - Tunisia 6
ES - Italia 5
LB - Libano 5
PK - Pakistan 5
UZ - Uzbekistan 5
AU - Australia 4
CO - Colombia 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
PY - Paraguay 4
BA - Bosnia-Erzegovina 3
PE - Perù 3
SN - Senegal 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
SA - Arabia Saudita 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BS - Bahamas 1
CL - Cile 1
CR - Costa Rica 1
DJ - Gibuti 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
KW - Kuwait 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
Totale 7.286
Città #
Chandler 528
Dublin 508
Singapore 479
Hong Kong 288
San Mateo 210
Perugia 178
Jacksonville 156
Boardman 140
Santa Clara 130
Ashburn 125
Medford 98
Princeton 98
Ann Arbor 97
Beijing 90
Andover 84
Dong Ket 75
Seoul 75
Wilmington 75
Moscow 69
Munich 60
Altamura 59
Lawrence 58
Los Angeles 46
Helsinki 34
Des Moines 33
New York 33
Ho Chi Minh City 29
Houston 28
Redwood City 27
Saint Petersburg 25
Dallas 24
São Paulo 24
Bucharest 21
Norwalk 20
Woodbridge 20
Piscataway 17
Brooklyn 16
Hanoi 16
Redmond 16
Turku 16
Warsaw 15
Falkenstein 14
Brussels 13
Tokyo 13
Atlanta 12
Coccaglio 12
Montreal 12
Chennai 11
Frankfurt am Main 11
Johannesburg 11
London 11
Rome 11
San Mauro Pascoli 11
The Dalles 11
Chicago 10
Nuremberg 10
Phoenix 10
Poplar 10
Stockholm 10
Dearborn 9
Izmir 9
San Paolo di Civitate 9
Terni 9
Vienna 9
Den Haag 8
Milan 8
Toronto 8
Denver 7
Mexico City 7
Rio de Janeiro 7
Falls Church 6
Guangzhou 6
Marsciano 6
Ankara 5
Boston 5
Manchester 5
Ribeirão Preto 5
Salvador 5
Shanghai 5
Amman 4
Auburn Hills 4
Bologna 4
Brasília 4
Calgary 4
Curitiba 4
Cusano Milanino 4
Erbil 4
Haiphong 4
Miami 4
Orem 4
San Francisco 4
Santo André 4
Seattle 4
Tianjin 4
Tunis 4
Wroclaw 4
Amsterdam 3
Araras 3
Baghdad 3
Barbacena 3
Totale 4.561
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 176
An Application of Conditional Robust Calibration (CRC) to The Lotka-Volterra Predator-Prey model in computational systems biology: a comparison of two sampling strategies 152
Cancer Registry and information technology: a new management system for integrating Cancer Registry and Oncology Departments 141
I Tumori multipli in Umbria. 124
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 115
Partecipazione al IV round dello screening citologico nella AUSL 2 dell’Umbria. 115
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 112
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 107
Cancer incidence in Italian contaminated sites 106
Incidence of multiple primary cancers following respiratory tract cancer in Umbria, Italy. 103
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 103
A Hybrid Model of Nucleotide Excision Repair in Neoplastic Diseases: The Identification Problem. 102
Spatial barriers impact upon appropriate delivery of radiotherapy in breast cancer patients 97
Effect of healthcare on mortality: trends in avoidable mortality in Umbria, Italy, 1994-2009 93
Robust Calibration of High Dimension Nonlinear Dynamical Models for Omics Data: An Application in Cancer Systems Biology 92
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 90
I tumori della tiroide 90
An approach for optimally extending mathematical models of signaling networks using omics data 90
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 89
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 89
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 89
A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments 88
Come misurare “l’impatto” dello screening colorettale nella Regione Umbria 88
A New Bayesian Methodology for Nonlinear Model Calibration in Computational Systems Biology 88
Information technology as tools for Cancer Registry and Regional Cancer Network integration 87
Cancer burden trends in Umbria region using a joinpoint regression 87
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 86
EPIDEMIOLOGIA DEL CANCRO DELL'ENDOMETRIO IN UMBRIA 86
An approach to the conditional robustness problem for biochemical networks 84
Registro Tumori, tecnologia informatica e rete oncologica regionale. Integrazione tra Registro Tumori e Servizi oncologici in Umbria. 83
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 83
A strategy for parameter estimation for mRNA and protein dynamics 81
I tumori dell'ovaio. 81
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology 81
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 81
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 79
I tumori del rene 79
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 79
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 79
Modelli dinamici per lo studio dei meccanismi di riparo del danno al DNA 78
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 78
THE EVOLVING ROLE OF CANCER REGISTRY: INFORMATION TECHNOLOGY AS TOOL FOR INTEGRATION WITH ONCOLOGY DEPARTMENTS 77
I tumori delle alte vie aero-digestive. 77
Regional indices of socio-economic and health inequalities: a tool for public health programming 77
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 76
Screening for colorectal cancer in Italy: 2011-2012 survey 76
Stadio alla diagnosi e controllo del cancro del grosso intestino in Umbria. 74
Cancer registry integration in the Umbria Regional Cancer Network: breast cancer as a model to build a supportive information system. 74
EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients. 73
La geografia del cancro in Umbria: incidenza 1978-2008. 73
Registro Tumori, tecnologia informatica e rete oncologica regionale: integrazione tra Registro Tumori e Servizi oncologici in Umbria. XIII Riunione annuale AIRTum. 72
Numeri dell'AIRTUM: 2000 giovani italiani vivono con il cancro. 72
MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non-small Cell Lung Cancer 70
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology (vol 30, pg 142, 2012) 70
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 70
Trend di incidenza e mortalità per cancro negli anziani in Umbria. 69
Staging, missing prognostic information and colorectal cancer control in Umbria 69
High coexpression of both insulin-like growth factor receptor 1 (igfr-1) and epidermal growth factor receptor (egfr) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients 69
Geographical suite for web management system of cancer registries 69
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 69
I tumori del pene e del testicolo. 68
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 68
Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. 67
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy 67
Dynamic modeling, parameter estimation and experiment design in Systems Biology with applications to Oncology 66
Epidemiology of HPV-related female cancers in the Umbria region of Italy: Pre-vaccination period 65
Seasonality of birth for skin melanoma deserves further investigation 65
Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer 64
I tumori della vescica. 64
Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology 63
Clinical significances of ErbB family receptors, Myc, and mitogen-activated protein kinase (MAPK) in patients with early-stage non-small cell lung cancer. 62
Gruppo multidisciplinare regionale per le neoplasie tiroidee, registro tumori e tecnologia informatica: integrazione tra registro tumori e specialisti di oncologia tiroidea in Umbria. 61
Narrative Medicine in Amyotrophic Lateral Sclerosis and a Rehabilitation Project Based on International Classification of Functioning, Disability and Health 61
Dynamic modeling and parameter identification for biological networks: application to the DNA damage and repair processes 61
Role of Expression Levels of Fabp3, H19, Tfpi2, Ark1b1 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients. 60
Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcome in Resected Non-Small Cell Lung Cancer Patients 57
Trends in invasive and in situ (CIN 3) cervical cancer incidence and mortality in Umbria, Italy: 1994-2008 55
What has changed in the epidemiology of skin melanoma in central Italy during the past 20 years? 55
Systems Biology and translational oncology: a case study of predictive modeling in molecular biology of the lung cancer 54
I numeri di AIRTUM: Buone notizie per i bambini italiani. Dopo il 2000 si arresta anche la crescita dei tumori maligni del sistema nervoso centrale. 54
Robustness of complex feedback systems: application to oncological biochemical networks 54
Envelope stress response in E.Coli: computational model 53
KRAS gene mutation testing an inter-laboratory validated workflow for quality assured, clinical-grade results using capillary electrophoresis. 53
Seasonal variation in the month of birth in patients with skin cancer 53
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 53
SYSTEMS BIOLOGY IN TRANSLATIONAL ONCOLOGY: COMPUTATIONAL AND EXPERIMENTAL STUDY OF EGFR AND IGF1R PATHWAYS IN NSCLC CELL LINES 51
INSULIN-LIKE GROWTH FACTOR RECEPTOR 1 (IGF1R) AND EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION AND EXPRESSION IN SURGICALLY RESECTED NSCLC 51
I tumori in Italia, rapporto 2011. La sopravvivenza dei pazienti oncologici in Italia. 51
Espressione dei recettori Her nei carcinomi non a piccole cellule del polmone. 50
MYC and human telomerase (TERC) gene copy number gain in resected non-small cell lung cancer (NSCLC) 48
Trend di mortalità per cause in Umbria. 1994-2010 47
Trend d’incidenza delle lesioni cervicali in situ ed infiltranti in Umbria. 46
Prognostic Role of Expression Levels of Fabp3, H19, Tfpi2, Akr1b10 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients 46
Cancer and Pregnancy: Estimates in Italy from Record-Linkage Procedures between Cancer Registries and the Hospital Discharge Database 45
Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients. 43
PROGNOSTIC AND PREDICTIVE ROLE OF PIK3CA MUTATIONS IN NON SMALL CELL LUNG CANCER PATIENTS TREATED WITH EGFR TYROSINE KINASE INHIBITORS (TKIS) 42
Genome-wide expression of the residual lung reacting to experimental Pneumonectomy 39
Influence of geographic barriers and care pathways on radiotherapy treatment and survival of breast cancer patients 38
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 36
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of MET, EGFR, KRAS, and PIK3CA mutations. 32
Totale 7.475
Categoria #
all - tutte 35.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021404 0 0 0 0 0 60 59 10 92 32 60 91
2021/2022830 20 144 9 47 12 5 13 288 29 27 93 143
2022/20231.601 109 249 33 127 127 170 0 73 650 2 54 7
2023/2024600 35 54 27 23 4 5 151 26 66 16 107 86
2024/20251.279 33 121 106 34 157 62 41 99 235 72 207 112
2025/20261.471 211 190 159 412 440 59 0 0 0 0 0 0
Totale 7.499